Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiac Event Risk”

201 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 201 results

Not applicableStudy completedNCT00753233
What this trial is testing

Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
National Heart, Lung, and Blood Institute (NHLBI) 145
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Not applicableWithdrawnNCT01330654
What this trial is testing

Heart Rate Variability (HRV) to Evaluate Surgical Risk on Patients on Beta Blockers

Who this might be right for
Cardiac Event Risk
University of California, San Francisco
Not applicableStudy completedNCT05708313
What this trial is testing

Effects of 9-18 Weeks of Intensive Cardiac Rehabilitation After a Major Cardiovascular Event in Patients With CVD

Who this might be right for
Cardiovascular DiseasesLifestyle Risk Reduction
Arkansas Heart Hospital 198
Post-approval studies (Phase 4)Study completedNCT07354230
What this trial is testing

Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACs

Who this might be right for
Atrial Fibrillation (AF)
Pirogov Russian National Research Medical University 210
Not applicableNot Yet RecruitingNCT07354828
What this trial is testing

Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 3,500
Not applicableStudy completedNCT03138109
What this trial is testing

Analysis of Incidence and Risk Factors of Severe Cardiovascular Events in Patients With Diastolic Dysfunction

Who this might be right for
Diastolic Dysfunction
Yan Zhou, MD 4,347
Not applicableNot Yet RecruitingNCT07441759
What this trial is testing

ThroMboembolic Risk Associated To High atrIal Fibrillation riSk

Who this might be right for
MACEAtrial Fibrillation (AF)Quality-adjusted Life-years+6 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,000
Post-approval studies (Phase 4)Study completedNCT00327418
What this trial is testing

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Who this might be right for
Major Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more
Pfizer 2,800
Not applicableStudy completedNCT07088718
What this trial is testing

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

Who this might be right for
Type 2 DiabetesMajor Adverse Cardiac EventsCardiovascular (CV) Risk
Brigham and Women's Hospital 44,671
Large-scale testing (Phase 3)Ended earlyNCT00263042
What this trial is testing

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Who this might be right for
Cardiovascular Disease
Sanofi 18,695
Not applicableStudy completedNCT04580108
What this trial is testing

Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 446
Not applicableActive Not RecruitingNCT07432620
What this trial is testing

Artificial Intelligence Stress Echo (FINESSE) Project

Who this might be right for
Coronary Artery DiseaseChest PainMyocardial Ischemia+2 more
Milton Keynes University Hospital NHS Foundation Trust 2,281
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Not applicableStudy completedNCT01398631
What this trial is testing

A Comparison of the TIMI, GRACE and HEART Scores

Who this might be right for
Acute Coronary Syndrome
R&D Cardiologie 2,440
Large-scale testing (Phase 3)Study completedNCT02344290
What this trial is testing

Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults

Who this might be right for
HIVCardiovascular Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 7,769
Not applicableStudy completedNCT01262222
What this trial is testing

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

Who this might be right for
High Risk for Postoperative Cardiovascular Events
Memorial Sloan Kettering Cancer Center 67
Not applicableUnknownNCT01589536
What this trial is testing

Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation.

Who this might be right for
Cardiovascular Events
Clinic Roderbirken 480
Not applicableLooking for participantsNCT06020209
What this trial is testing

CCT for Comprehensive Risk Stratification Following STEMI

Who this might be right for
Myocardial Infarction
University of Turin, Italy 200
Large-scale testing (Phase 3)Study completedNCT00799903
What this trial is testing

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Who this might be right for
Atherosclerosis
GlaxoSmithKline 15,828
Load More Results